Presentation

Poster

  • L. McLean, C. Casiano, U. Soto, L. C. Sowers and Eileen Brantley. "Growth inhibitory effects of Aminoflavone in estrogen receptor negative MDA-MB-468 breast cancer cells. "Proceedings of the American Association for Cancer Research 47. (2006) (07/2010 - 06/2011)
  • McLean L., Davis, W.L., Jr., Sowers L. and Brantley E. 5F 203-induced apoptosis involves oxidative stress and caspase activation in sensitive breast cancer cells. Presented at the 99th Annual American Association for Cancer Research meeting, San Diego, CA ( 4/2008) (07/2010 - 06/2011)
  • E. Brantley, C. Watkins, L. McLean, L. Amis and W. Davis. 5F 203 modulates oxidative stress, induces single strand breaks and promote mitochondrial membrane potential loss in breast cancer cells. Poster presentation at the American Association for Cancer Research (4/2010) (07/2010 - 06/2011)
  • L. P. Edwards and L. S. McLean. Moxonidine an Antihypertensive Agent Sensitizes Cancer Cells to Apoptosis. IADR/AADR/CADR 89th General Session and Exhibition. (2011) (07/2010 - 06/2011)
  • N. A. Johnson, L. S. McLean and L. P. Edwards. Hibiscus Sabdariffa Induces Cell Death in Oral Squamous Carcinoma Cells. IADR/AADR/CADR 89th General Session and Exhibition (2011) (07/2010 - 06/2011)
  • Antiproliferative mechanism of novel imidazoline compound in PC12 cells. L. S. McLean, L. Crane and G. Baziard-Mouysset and L. P. Edwards. Experimental Biology Annual Meeting, 2013. (07/2012 - 06/2013)
  • Apoptotic mechanism of novel anticancer agents is mediated by MAPKs in breast cancer cells. L. S. McLean, and E. Brantley. Experimental Biology Annual Meeeting, 2013 (07/2012 - 06/2013)
  • Imidazoline compounds as antihypertensive and anticancer agents. L. S. McLean, L. Crane and G. Baziard-Mouysset and L. P. Edwards. IADR/AADR/CADR General Session and Exhibition (2013) (07/2012 - 06/2013)
  • Investigational agent 5F 203 modulates apoptotic regulatory gene expression and   induces lysosomal membrane permeabilization in breast cancer cells. Eileen Brantley and L. S. McLean. Presented at the Annual AACR meeting, Washington, DC. April 2013. (07/2012 - 06/2013)

Research

  • The effect of moxonidine on sensitization of oral cancer cells to cetuximab (Center for Dental Research)   (07/2012 - 06/2013)